Chemical Formula: C9H15NO2

Chemical Formula C9H15NO2

Found 72 metabolite its formula value is C9H15NO2

3,3-Diethyl-2,4-dioxopiperidine

R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent

Homoarecoline

Ethyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylic acid

C9H15NO2 (169.110273)

Homoarecoline is found in nuts. Homoarecoline is isolated from betel nuts. Isolated from betel nuts. Homoarecoline is found in nuts.

Nortropine acetate

3alpha-Acetoxynortropane

C9H15NO2 (169.110273)

ethyl 2-aminocyclohex-1-enecarboxylate

C9H15NO2 (169.110273)

Diacetoneacrylamide

N-(1,1-dimethyl-3-oxobutyl)acrylamide

C9H15NO2 (169.110273)

CONFIDENCE standard compound; INTERNAL_ID 493; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5892; ORIGINAL_PRECURSOR_SCAN_NO 5888 CONFIDENCE standard compound; INTERNAL_ID 493; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5924; ORIGINAL_PRECURSOR_SCAN_NO 5922 CONFIDENCE standard compound; INTERNAL_ID 493; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5925; ORIGINAL_PRECURSOR_SCAN_NO 5923 DATASET 20200303_ENTACT_RP_MIX506; CONFIDENCE standard compound; INTERNAL_ID 493; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5947; ORIGINAL_PRECURSOR_SCAN_NO 5945 CONFIDENCE standard compound; INTERNAL_ID 493; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5947; ORIGINAL_PRECURSOR_SCAN_NO 5945 CONFIDENCE standard compound; INTERNAL_ID 493; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5961; ORIGINAL_PRECURSOR_SCAN_NO 5958 CONFIDENCE standard compound; INTERNAL_ID 493; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5955; ORIGINAL_PRECURSOR_SCAN_NO 5953 CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 1091

S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EB - Parasympathomimetics D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010277 - Parasympathomimetics D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D008916 - Miotics C78272 - Agent Affecting Nervous System > C47796 - Cholinergic Agonist Aceclidine (Quinuclidin-3-yl acetate) is a modulator of M3 muscarinic acetylcholine receptor and a M1 receptor agonist (EC50: 40 μM). Aceclidine is a cycloplegic agent, a surfactant, a tonicity adjustor and optionally a viscosity enhancer and an antioxidant. Aceclidine has the potential for the research of disorders such as refractive errors of the eye, xerostomia, Sjogren's syndrome, glaucoma, conjunctivitis, lacrimal gland disease, and esotropia[1][2][3].